Timothy W. Trost

2021 - Werewolf Therapeutics

In 2021, Timothy W. Trost earned a total compensation of $2.1M as Chief Financial Officer at Werewolf Therapeutics.

Compensation breakdown

Bonus$142,000
Option Awards$1,608,910
Salary$337,793
Other$1,346
Total$2,090,049

Trost received $1.6M in option awards, accounting for 77% of the total pay in 2021.

Trost also received $142K in bonus, $337.8K in salary and $1.3K in other compensation.

Rankings

In 2021, Timothy W. Trost's compensation ranked 5,884th out of 12,415 executives tracked by ExecPay. In other words, Trost earned more than 52.6% of executives.

ClassificationRankingPercentile
All
5,884
out of 12,415
53rd
Division
Manufacturing
2,488
out of 5,505
55th
Major group
Chemicals And Allied Products
1,080
out of 2,375
55th
Industry group
Drugs
961
out of 2,096
54th
Industry
Pharmaceutical Preparations
691
out of 1,546
55th
Source: SEC filing on April 22, 2022.

Trost's colleagues

We found four more compensation records of executives who worked with Timothy W. Trost at Werewolf Therapeutics in 2021.

2021

Chulani Karunatilake

Werewolf Therapeutics

Chief Technology Officer

2021

Daniel Hicklin

Werewolf Therapeutics

Chief Executive Officer

2021

Randi Isaacs

Werewolf Therapeutics

Chief Medical Officer

2021

Cynthia Seidel-Dugan

Werewolf Therapeutics

Chief Scientific Officer

News

In-depth

You may also like